Find Academic Supervisors

• Bioorganic Chemistry
• Nucleic Acids Chemistry
• Breast Cancer Imaging
• +3 more

John-Stephen Taylor is a Professor of Chemistry at Washington University. His research focuses on bioorganic chemistry, nucleic acids, and the molecular mechanisms underlying skin cancer and chemotherapy. He holds a SB from MIT and a PhD from Columbia University. Education: PhD in Chemistry, Columbia University SB in Chemistry, Massachusetts Institute of Technology Research Interests: Taylor’s work explores how sunlight-induced DNA damage (e.g., cyclobutane pyrimidine dimers) contributes to skin cancer, particularly via novel pathways involving dioxetanes and chromatin structures. He also investigates natural products that modulate heat shock proteins. Methodologies include NMR spectroscopy, NextGen sequencing, and cell culture. Article Trends: His publications emphasize photoproduct formation mechanisms, nucleosome dynamics, and telomeric DNA behavior under UV exposure. Recent work highlights structural insights into DNA repair and mutagenesis pathways. Awards: Phi Beta Kappa (1975) NIH Merit Award (1993–2001) Special Recognition for Excellence in Mentoring (2005–2007) Grants & Advising: Taylor has received sustained NIH funding and is recognized for mentoring. His lab employs interdisciplinary approaches, combining synthetic chemistry with genomic and structural biology techniques.

• Epidermal Stem Cell Biology
• Epigenetics
• Developmental Biology
• +4 more

George Sen is a Professor at the University of California, San Diego (UCSD) within the Department of Cellular and Molecular Medicine . His research focuses on the molecular mechanisms of epidermal stem cell self-renewal and differentiation , aiming to understand how disruptions in this balance contribute to skin disorders like psoriasis and carcinomas. Research areas: Developmental Biology, Genetics and Genomics, Epigenetics, Stem Cell Biology Current NIH grants: R01CA225463 (2018-2023), R01AR072590 (2018-2023), R01AR066530 (2015-2026) His work emphasizes epigenetic factors such as HDACs, DNMT1, and RNA-binding proteins in maintaining stem cell identity and driving differentiation. Recent publications highlight collaborations with researchers like Ye Liu , Uyanga Batzorig , and Richard Gallo on topics including UVB-induced skin inflammation, transcriptional elongation, and immune tolerance. Articles show strong representation in Cell Biology , Dermatology , and Allergy/Immunology , with subfields spanning RNA processing , chromatin dynamics , skin tumorigenesis , and cytoplasmic body function . The Sen Lab at UCSD continues to explore novel regulators of epidermal homeostasis through NIH-funded projects.

• Computational Genomics
• Maternal-Fetal Medicine
• Placental Biology
• +3 more

Kathleen Fisch, PhD is an Assistant Professor at the University of California, San Diego School of Medicine, Department of Obstetrics, Gynecology and Reproductive Sciences. She serves as Faculty Director of the Center for Computational Biology & Bioinformatics (CCBB) and Co-Director of the ACTRI Center for Excellence in Translational Immunogenomics (CETI), leading initiatives in computational genomics and bioinformatics infrastructure. University of California, Berkeley: B.A. in Integrative Biology University of California, Davis: Ph.D. in Ecology (Population Genetics) Her research focuses on genomic and computational approaches to maternal-fetal medicine, placental biology, and translational immunogenomics. This includes studies on preeclampsia, HPV-mediated cancers, and SARS-CoV-2 placental transmission using multi-omics and systems biology frameworks. Key publication trends include: Genomic analysis of placental lesions in preeclampsia Single-cell transcriptomics in reproductive tissues Computational modeling of pain signatures and opioid addiction HPV extrachromosomal DNA in oropharyngeal cancer Epigenetic regulation in viral infections and autoimmune conditions Dr. Fisch collaborates on NIH-funded projects including R21HD110893 (Placental Lesions in Preeclampsia), U54HD110347 (Pregnant Female Reproductive Tissue Mapping), and U54DA049115 (Acute to Chronic Pain Signatures Program).

Niall BarronView profile

Professor

• Biomedical Engineering
• Biochemical Engineering
• Cellular and Molecular Biology
• +5 more

Professor Niall Barron is a Professor of Biochemical Engineering at the School of Chemical and Bioprocess Engineering, University College Dublin (UCD), and a Principal Investigator at the National Institute for Bioprocessing Research and Training (NIBRT). He holds a BA (Mod) in Microbiology from Trinity College Dublin and a PhD in Applied Microbiology/Biochemistry from the University of Ulster (1997). His postdoctoral research at Baylor College of Medicine focused on nuclear steroid receptor function via genome engineering. He has held academic and research roles at Dublin City University (DCU), including Director of the National Institute for Cellular Biotechnology (NICB) from 2015–2017. His research focuses on genetic engineering strategies to improve recombinant protein production in CHO cells, AAV/LV vector manufacturing, and epigenetic regulation of bioprocess performance. He leads projects funded by industry and EU grants, including initiatives to enhance gene therapy vector production and mRNA methylation control. Education: BA (Mod) in Microbiology, Trinity College Dublin PhD in Applied Microbiology/Biochemistry, University of Ulster (1997) Research Interests: Targeted genome editing in CHO cells for improved biopharmaceutical production Optimization of AAV and LV vector systems for gene therapy miRNA and epitranscriptomic regulation of cellular processes Single-cell analysis to understand clonal variability and production instability Grants & Collaborations: Lead on grants from GSK, Enterprise Ireland, and Horizon 2020 (e.g., STACCATO, GeneClick) Focus on advancing bioprocess technologies and cell line engineering Teaching: Coordinates modules in biopharmaceutical manufacturing, biotechnology principles, and gene therapy processes Program Director for the MEngSc in Biopharmaceutical Manufacturing (Part-Time) Labs & Teams: Leads a multidisciplinary team at UCD and NIBRT focusing on biopharmaceutical engineering and cell line optimization

• Cancer Biology
• Cell Biology
• Molecular Biology
• +2 more

Nirakar Rajbhandari is an Assistant Project Scientist in the Department of Surgery at the University of California, San Diego (UCSD). His research focuses on pancreatic cancer biology, tumor microenvironment dynamics, and cancer stem cell mechanisms. He actively contributes to translational medicine through collaborative publications in premier journals. Current Affiliation: Department of Surgery, UCSD Research Interests: Cancer Biology, Cell Biology, Molecular Oncology Dr. Rajbhandari's research explores pancreatic cancer metastasis, tumor dormancy mechanisms, and epigenetic regulation of cancer progression. His work often involves single-cell analysis, mouse models, and signaling pathway investigations. Recent publications (2023-2025) show increasing focus on epigenetic modulation , single-cell heterogeneity , and pancreatic cancer subtypes . Key methodologies include RNA sequencing and protein interaction analysis. Selected Collaborators: Andrew Lowy (UCSD) Marcie Kritzik (UCSD) Bharti Garg (UCSD) Roman Sasik (UCSD) Kwun Wah Wen (UCSF) His work appears in journals like Cancer Research , Nature Communications , and Cell , with citations in both basic and clinical research contexts.

Paula M. VertinoView profile

Professor

• Cancer Epigenetics
• Gene Silencing Mechanisms
• Cancer Genomics
• +3 more

Dr. Paula M. Vertino is a distinguished academic holding multiple roles at the University of Rochester: Professor in the Department of Biomedical Genetics and Department of Pathology and Laboratory Medicine, Wilmot Distinguished Professorship in Cancer Genomics , and Senior Associate Dean for Basic Research in the School of Medicine and Dentistry. Her research focuses on cancer epigenetics , gene silencing mechanisms , and cancer genomics , with emphasis on DNA methylation, histone modifications, and their roles in tumorigenesis. Key contributions include studies on the interplay between epigenetic regulation and cellular invasion, the impact of exercise on cancer survivorship, and mechanisms of drug resistance in multiple myeloma. She has pioneered work on chromatin accessibility profiling and the role of transposon DNA in tumor progression. Dr. Vertino’s work bridges basic science and clinical translation, with recent studies addressing aging-related cancer biology and the application of mobile health interventions in oncology. She holds the Wilmot Distinguished Professorship, a testament to her impactful contributions to cancer research. Her interdisciplinary research involves collaborations across departments (Pathology, Genetics, Oncology) and institutions, addressing topics such as tumor microenvironment dynamics and epigenetic therapy development. She leads initiatives in basic research administration, shaping the strategic direction of translational science at the University of Rochester.

• Genomics
• Epigenetics
• Personalised Health
• +4 more

Dr Anita Sathyanarayanan is a Postdoctoral Research Fellow at the Centre for Genomics and Personalised Health, University of New South Wales. Her work focuses on integrating multi-omics data to understand complex diseases such as psychiatric disorders, cancers, and infectious diseases. She specializes in epigenetic mechanisms, genetic risk prediction, and translational biomarker discovery. Key research areas include: Epigenetic effects of trauma and childhood adversity Genetic links between blood analytes and severe diseases Multi-omics approaches for PTSD and cancer subtyping Pharmacogenetic optimization of lithium therapy Her methodological contributions span bioinformatics tool development for omics integration, ChIP-Seq analysis, and exome sequencing interpretation. Current projects emphasize personalized medicine applications in oncology and mental health. Lab affiliations: Centre for Genomics and Personalised Health (UNSW)

Amanda StormView profile

Associate Professor

• Protein Biochemistry
• Molecular Biology
• Plant Genetics
• +3 more

Dr. Amanda Storm is an Associate Professor of Biology at Western Carolina University (WCU), affiliated with the College of Arts and Sciences. Her research focuses on understanding protein sequence-structure-function relationships, particularly in plants, aiming to leverage this knowledge for agricultural innovation and medical applications. She teaches courses including General Biology, Biotechnology, Introductory Genetics, and Protein Bioinformatics. Education: Ph.D., Miami University, Ohio B.S., Central State University, Ohio Postdoctoral Research at James Madison University Research Interests: Dr. Storm’s lab investigates protein interactions and functional diversity through approaches like transgenic plant generation, enzyme kinetics, and molecular cloning. Key areas include optimizing crops for climate resilience and identifying antibiotic targets. Recent projects focus on cotton genome annotation and Arabidopsis β-amylase enzyme dynamics. Articles Overview: Her publications emphasize plant genetics, enzyme regulation, and protein structure-function relationships, with a focus on cotton and Arabidopsis systems. Themes include gene annotation, stress tolerance mechanisms, and metabolic pathway regulation. Lab & Students: Undergraduate and graduate students in her lab engage in projects spanning plant genetics, bioinformatics, and enzyme analysis. No specific grants or awards are listed, but her work contributes to foundational understanding of plant molecular biology.

Emiliano MaianiView profile

Associate Professor

• Molecular Biology
• Oncology
• Cell Signaling
• +6 more

Emiliano Maiani is an Associate Professor of Molecular Biology at UniCamillus and serves as Vice Dean of the Departmental Faculty of Medicine. He holds concurrent roles as Research Delegate coordinating the University’s Integrated Research Center and Visiting Scientist at the Danish Cancer Institute. His expertise lies in cellular signaling mechanisms, particularly DNA damage response, autophagy regulation, and S-nitrosylation pathways. He earned his Ph.D. in Cellular and Molecular Biology from the University of Rome Tor Vergata (2013) and conducted postdoctoral research at the Danish Cancer Society Research Center until 2021. His research focuses on molecular mechanisms underlying cancer progression, genomic stability, and cell cycle control. Key areas include GSNOR-mediated regulation of tumor growth, AMBRA1’s role in cyclin D stability, and autophagy’s role in tissue homeostasis. He has published in high-impact journals like Nature and Nature Medicine , with recent work addressing S-nitrosylation in embryonal rhabdomyosarcoma and tendon biology. Maiani serves as a peer reviewer for major scientific journals and evaluates national and EU research projects (Horizon Europe, Marie Skłodowska-Curie Fellowships). His collaborative efforts span computational biology, structural bioinformatics, and protein disorder prediction through initiatives like DisProt database improvements. He also contributes to methodological standards in autophagy research via guideline publications.

• Molecular Genetics
• Epigenetics
• Cancer Biology
• +5 more

Carol IMBRIANO is an Associate Professor at the University of Modena and Reggio Emilia, Department of Life Sciences ex-Biology. She specializes in molecular genetics, epigenetics, and their applications in cancer biology and medical biotechnology. Her research focuses on transcription factors like NF-Y, particularly their roles in tumor progression, metabolic reprogramming, and epigenetic regulation. She also develops biosensor technologies using organic electrochemical transistors for DNA detection. Her teaching responsibilities include courses on molecular genetics and epigenetics for biosciences, genetics laboratory work for biotechnology students, and personalized therapy modules in medical biotechnology. These courses integrate theoretical and practical components, such as bioinformatics analysis and lab safety protocols. She emphasizes critical thinking and data interpretation through written and oral exams, often using international scientific literature. Research interests revolve around the molecular mechanisms underlying cancer aggressiveness, including NF-Y splicing dynamics in metastasis, estrogen receptor interactions in prostate cancer, and sigma-2 receptor targeting for melanoma therapy. She explores how epigenetic modifications (e.g., DNA methylation, histone variants) contribute to disease development and leverages nanomedicine for therapeutic delivery and diagnostic innovation. Her work bridges basic science with clinical applications in precision medicine and cancer stratification. Publications consistently highlight advanced topics in transcription factor biology, cancer metabolism, and nanosensor development. She collaborates with multidisciplinary teams on projects like EGOT biosensors and drug discovery for CRPC. Despite her extensive contributions, no scientific awards or grants are explicitly listed in the provided texts. She maintains an open-door policy for students via prior arrangement and uses digital platforms like Teams for course materials.

• Cancer Immunotherapy
• Genomic Analysis
• Tumor Suppressor Genes
• +3 more

Jiali Zhang is a Postgraduate Associate in the Department of Pathology at the Yale School of Medicine. Her research focuses on cancer genomics, tumor suppressor pathways, and molecular mechanisms of HPV-associated cancers. She has contributed to advancements in cell-based immunotherapies, CRISPR-based functional genomics, and translational diagnostics. Her work integrates genomic analysis with clinical applications, particularly in lung cancer, head and neck cancers, and colorectal cancer. Key projects include investigating TRAF3's tumor suppressor role, epigenetic modifications in lung cancer, and single-cell sequencing for precision medicine. She has developed novel assays for studying tumor-immune interactions and cancer cell cytotoxicity. Publications span topics such as alternative NF-κB signaling in HPV+ cancers, biomarker discovery for colorectal cancer, and combination therapies overcoming drug resistance in head and neck tumors. Her research bridges basic science and clinical practice, emphasizing diagnostic innovation and therapeutic target identification. Though no specific awards or grants are listed in the provided text, her extensive publication record reflects sustained contributions to cancer biology and translational oncology.

• Bioinformatics
• Genetics
• Cancer Biology
• +3 more

Chuanpeng Dong is a Research Fellow in the Department of Genetics at Yale University, part of the Yale School of Medicine. He holds a PhD in Bioinformatics from Indiana University, an MS in Biochemistry and Bioinformatics from Fudan University, and a BS from Jilin University. Prior to his postdoctoral position, he gained industry experience as a research assistant at Hengrui Medicine (2012-2014). His research focuses on integrative genomics, CRISPR-based technologies, and bioinformatics tools to study cancer biology, neurodegenerative diseases (e.g., Alzheimer's), and immune responses. Key projects include developing spatial CRISPR screening methods (e.g., perturb-DBiT), analyzing microglial roles in aging, and creating databases like TCPGdb for T-cell perturbation studies. Research interests span genetic regulation of miRNA biogenesis, alternative splicing in cancers, and biomarker discovery using tools like CGPE and DEGAS. His work bridges computational biology with experimental validation to uncover mechanisms underlying disease pathogenesis and therapeutic responses. Publications highlight contributions to understanding CRISPR-therapeutic interactions, immunotherapy optimization, and neurodegenerative processes linked to PLCG2 variants and ELP3 dysfunction. His interdisciplinary approach merges genomics, proteomics, and computational modeling to address complex biomedical challenges.

Jerome MenetView profile

Associate Professor

• Circadian Rhythms
• Molecular Biology
• Gene Expression Regulation
• +5 more

Jerome Menet is an Associate Professor at Texas A&M University, leading the Menet Lab. He specializes in circadian biology, focusing on molecular mechanisms underlying circadian clocks and their impact on health. His research explores how clock genes regulate gene expression, linking circadian dysfunction to diseases like cancer, metabolic disorders, and neurodegeneration. Menet holds a B.Sc. in Molecular and Cellular Biology from the University of Lille (1996), followed by an M.Sc. and Ph.D. in Neurosciences from Louis Pasteur University (1999 and 2003). He completed postdoctoral research at Brandeis University before joining Texas A&M in 2013. His research integrates molecular and biochemical techniques, including next-generation sequencing, to study genome-wide circadian regulation. Key areas include chromatin dynamics and post-transcriptional control of gene expression. Recent work highlights the role of rhythmic food intake in driving gene expression patterns more potently than intrinsic circadian clocks, with implications for metabolic health. Publications span circadian-cancer links, chromatin architecture, and rhythmic RNA processing. Menet’s lab develops custom tools like feeding systems to model circadian disruptions. Despite no explicitly listed awards, his work has been published in high-impact journals such as Nature and Cell Reports. Advising and grants: Menet supervises students in his lab, though no specific advisees are named. Grants and collaborations underpin his research, though specifics are not detailed here. His lab focuses on translational research, bridging fundamental circadian biology with clinical applications. Labs/teams: The Menet Lab at Texas A&M is a hub for circadian research, employing interdisciplinary approaches to dissect molecular mechanisms and disease connections. Ongoing projects aim to expand understanding of chromatin regulation and post-transcriptional pathways in circadian contexts.

• Immunology
• Clinical Sciences
• Oncology and Carcinogenesis
• +3 more

Dr. Jennifer Boer is a Postdoctoral Research Fellow at RMIT University's Research & Innovation Capability department in Bundoora West, Australia. Her research focuses on immunology, clinical sciences, oncology, nanotechnology, and medical health sciences, with a particular emphasis on vaccine development, nanomedicine, and infectious disease mechanisms. She is actively involved in supervising Masters and PhD students, including projects like 'Metagenetic Approach to Analyse Vaccine Immunomodulation in the Elderly' and 'Gold-based drugs for the effective treatment of ovarian cancer'. Her work spans interdisciplinary areas, such as vaccine delivery systems using liposomes and polymeric nanoparticles, and the study of SARS-CoV-2 mutations affecting protein flexibility. She also explores ethical and statistical aspects of animal experimentation design. Dr. Boer collaborates widely, contributing to fields like environmental microbiology, drug discovery pedagogy, and glaucoma immunotherapy. Her recent publications highlight advancements in vaccine adjuvants, anaerobic sewage sludge analysis, and the role of tumor necrosis factor receptors in disease. She is open to mentoring students in these and related areas.

Zhang XiurenView profile

Professor

• RNA silencing
• RNA structure and remodeling
• ribonucleoprotein complexes
• +5 more

Zi Zhang Xiuren is the Christine Richardson Endowed Professor of Agricultural Biology and holds the rank of Professor in the Department of Biochemistry & Biophysics at Texas A&M University's College of Agriculture & Life Sciences. He is also an EDGES Fellow, Presidential Impact Fellow, and AgriLife Faculty Fellow. His research focuses on RNA silencing pathways, RNA structure remodeling, and host-virus interactions in plants. He employs genetic, molecular, and biochemical approaches to study miRNA and siRNA-mediated regulation, epigenetic mechanisms, and viral defense strategies. Key contributions include identifying components of RNA silencing pathways and elucidating the roles of RNA structure and epigenetic modifications in plant development and immunity. Education: B.S. from Hefei College of Economy and Technology (1989), Ph.D. in Molecular Genetics from Cornell University (2003), and postdoctoral training at Rockefeller University (2008). Research Interests: RNA silencing mechanisms and their roles in plant growth and antiviral defense RNA secondary structure (RSS) and epi-modifications (REM) in gene expression regulation Host-virus interactions, particularly with Geminivirus and Cucumber Mosaic Virus Epigenetic suppression by viral proteins like TrAP Awards & Fellowships: Christine Richardson Endowed Professorship Presidential Impact Fellow EDGES Fellow AgriLife Faculty Fellow Grants & Advising: Active in securing research grants and mentoring students in molecular genetics and plant biology. His lab collaborates on projects involving miRNA biogenesis, viral suppression mechanisms, and epigenetic regulation. Labs & Teams: Leads a research group focused on RNA biology at Texas A&M, contributing to initiatives like the Texas A&M AgriLife Research program.